ECONOMIC BURDEN AMONG CHRONIC KIDNEY DISEASE (CKD) PATIENTS WITH AND WITHOUT TYPE 2 DIABETES (T2D) IN A COMMERCIALLY INSURED/MEDICARE ADVANTAGE (MA) POPULATION IN THE UNITED STATES (US)

被引：0
|
作者：
Chung, H. [1 ]
Thomas, N. [1 ]
Willey, V [1 ]
Kong, S. X. [2 ]
Singh, R. [2 ]
Farej, R. [2 ]
Williamson, T. [2 ]
机构：
[1] HealthCore Inc, Wimlington, DE USA
[2] Bayer US LLC, Whippany, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE242
引用
收藏
页码：S381 / S381
页数：1
相关论文
共 50 条
  • [41] THE IMPACT OF TYPE 2 DIABETES (T2D) ON THE OUTCOMES OF LIVER TRANSPLANTATION (LT) AMONG PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE (ALD) IN THE UNITED STATES
    Stepanova, Maria
    Wong, Robert
    Singal, Ashwani
    Nguyen, Veronica
    Henry, Linda
    Alqahtani, Saleh
    Younossi, Zobair
    HEPATOLOGY, 2024, 80
  • [42] Incidence of Chronic Kidney Disease and Progression of Kidney Dysfunction Among Patients With and Without Type 2 Diabetes
    Nichols, Gregory A.
    Derauz-Luyet, Anouk
    Hauske, Sibylle J.
    Brodovicz, Kimberly G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 482 - 482
  • [43] ASSESSMENT OF THE HIGH RISK AND UNMET NEED IN PATIENTS WITH CAD AND TYPE 2 DIABETES (ATHENA): US BURDEN OF ILLNESS IN A COMMERCIALLY-INSURED POPULATION
    Wittbrodt, Eric
    Bhalla, Narinder
    Sundell, Karolina Andersson
    Hunt, Phillip
    Rudnik, Janek
    Wong, Nathan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 38 - 38
  • [44] Antidiabetic Medication Use and Prevalence of Chronic Kidney Disease Among Patients With Type 2 Diabetes Mellitus in the United States
    Koro, Carol E.
    Lee, Bo Hyen
    Bowlin, Steve J.
    CLINICAL THERAPEUTICS, 2009, 31 (11) : 2608 - 2617
  • [45] A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States
    Lin, Yilu
    Shao, Hui
    Fonseca, Vivian
    Anderson, Amanda H.
    Batuman, Vecihi
    Shi, Lizheng
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2862 - 2868
  • [46] A Prediction Model of Chronic Kidney Disease Progression among Individuals with Type 2 Diabetes in the United States
    Lin, Yilu
    Shao, Hui
    Anderson, Amanda H.
    Fonseca, Vivian
    Batuman, Vecihi
    Shi, Lizheng
    DIABETES, 2022, 71
  • [47] Change in Albuminuria Measured by Urine Albumin-toCreatinine Ratio (UACR) and Associated Clinical Outcomes in Patients With Chronic Kidney Disease (CKD) Associated With Type 2 Diabetes (T2D)
    Tangri, Navdeep
    Li, Qixin
    Chen, Yan
    Singh, Rakesh
    Betts, Keith A.
    Farag, Youssef M.
    Beeman, Scott
    Du, Yuxian
    Kong, Sheldon X.
    Williamson, Todd
    Wu, Aozhou
    Sundar, Manasvi
    Pantalone, Kevin M.
    CIRCULATION, 2023, 148
  • [48] Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
    Kovesdy, Csaba P.
    Isaman, Danielle
    Petruski-Ivleva, Natalia
    Fried, Linda
    Blankenburg, Michael
    Gay, Alain
    Velentgas, Priscilla
    Folkerts, Kerstin
    CLINICAL KIDNEY JOURNAL, 2021, 14 (06) : 1657 - 1664
  • [49] FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Pochopien, Michal T.
    Cherney, David Z., I
    Folkerts, Kerstin
    Levy, Pierre
    Millier, Aurelie
    Morris, Stephen
    Roy-Chaudhury, Prabir
    Sullivan, Sean D.
    Mernagh, Paul
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (20): : S375 - S382
  • [50] Incidence and Prevalence of Microvascular and Macrovascular Diseases and All-cause Mortality in Type 2 Diabetes Mellitus: A 10-year Study in a US Commercially Insured and Medicare Advantage Population
    Visaria, Jay
    Iyer, Neeraj N.
    Raval, Amit
    Kong, Sheldon
    Hobbs, Todd
    Bouchard, Jonathan
    Kern, David M.
    Willey, Vincent
    CLINICAL THERAPEUTICS, 2019, 41 (08) : 1522 - 1536
12345